Seeking Alpha

QualityStocks'  Instablog

QualityStocks
Send Message
QualityStocks (www.qualitystocks.net) assists publicly traded companies by getting their story out to the investment community while helping investors discover emerging companies with plenty of growth potential. Our name, QualityStocks, emphasizes our commitment to connect subscribers with... More
My company:
QualityStocks
My blog:
QualityStocks Micro-Cap and Small-Cap Blog
  • FDA Approves Cellceutix Corp. (CTIX) Proposed Phase I Clinical Trial For Anti-Cancer Compound 0 comments
    Jun 22, 2012 5:24 PM | about stocks: CTIX

    Biopharm company Cellceutix today said the U.S. Food and Drug Administration (FDA) has reviewed the company's Investigational New Drug (NYSE:IND) application for its novel anti-cancer compound Kevetrin™ and has approved the company's advancement to phase I clinical trial.

    The phase 1 clinical trial for Kevetrin will take place at Harvard Cancer Center's Dana-Farber Cancer Institute and partner Beth Israel Deaconess Medical Center.

    The company also announced that both the Institutional Review Board and the Scientific Review Committee have approved the protocol for the clinical trial.

    Cellceutix said it will provide details on the commencement of the clinical trials to shareholders next week.

    Cellceutix is focused on the discovery of small molecule drugs to treat unmet medical conditions, including drug-resistant cancers and autoimmune diseases. In addition to its flagship compound Kevetrin, the company owns the rights to seven other drug compounds, including KM-133 in development for psoriasis, and KM-391 for the treatment of the core symptoms of autism.

    For more information visit cellceutix.com

    Please see disclaimer on the QualityStocks website: disclaimer.qualitystocks.net

    Stocks: CTIX
Back To QualityStocks' Instablog HomePage »

Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.

Comments (0)
Track new comments
Be the first to comment
Full index of posts »
Latest Followers

StockTalks

More »
Posts by Themes
Instablogs are Seeking Alpha's free blogging platform customized for finance, with instant set up and exposure to millions of readers interested in the financial markets. Publish your own instablog in minutes.